2020 Pharmacogenomics Access and Reimbursement Symposium
Uniting Internationally to Advance Precision Medicine
October 7-8, 2020, Washington DC, USA
The Golden Helix Foundation and the Pharmacogenomics Access & Reimbursement Coalition (PARC) are proud to announce our inaugural hosting of the Pharmacogenomics Access & Reimbursement Symposium (PARS) on October 8, 2020, at the National Academy of Sciences in Washington D.C.
The theme of the symposium is “Uniting Internationally to Advance Precision Medicine”.
A primary goal of PARC continues to be the exchange of ideas and experiences among stakeholders that share similar opportunities and challenges in pharmacogenomics. The symposium will provide presentations by industry and thought leaders during key sessions including Health Technology Assessment, Health Economics and Value-based Payment Strategies for Pharmacogenomics.
Decision-makers from industry, government agencies, payer organizations, health systems and health policy organizations will convene to define opportunities to improve patient access to precision medicine through best practices, successful reimbursement models, high quality economic evaluations and strategic alignment.
We anticipate international representation from the Golden Helix Foundation’s Genomic Medicine Alliance of 1,400 members from over 70 countries around the world. Live symposium webcasting will allow virtual attendance to expand reach and will increase exposure of your support.
We look forward to your partnership in our efforts to improve patient access to safer and more effective treatments using precision medicine.
The PARS 2020 Organizing Committee